Central sleep apnea is a sleep-related breathing disorder where the brain does not send steady signals to breathe. People with central sleep apnea often have pauses in breathing during sleep and wake up feeling unrefreshed. It can be lifelong when linked to neurologic disease or heart failure, and it can also appear after high-altitude exposure, certain medicines, or stroke. Adults are most often affected, but children can be affected when there is an underlying brain or heart condition. Treatment focuses on the cause and may include optimizing heart care, adjusting medications, oxygen, or specialized positive airway pressure, and the outlook varies with severity and other health issues.
Overview
Central sleep apneaSymptoms
Central sleep apnea causes brief breathing pauses during sleep, often noticed by a bed partner, with restless nights and awakenings. Common symptoms include daytime sleepiness, morning headaches, trouble concentrating, and waking short of breath; snoring may be mild or absent.
Outlook and prognosis
Most people with central sleep apnea improve with targeted treatment, like optimizing heart or brain-related conditions, adjusting medications, and using breathing support at night. Symptoms often ease, sleep quality rises, and daytime alertness returns. Long-term outlook depends on the underlying cause and timely follow-up.
Causes and risk factors
Central sleep apnea can be triggered by heart failure, stroke, brain conditions affecting breathing control, high altitude, opioid pain medicines, or CPAP treatment for obstructive apnea. Risk rises with older age, male sex, atrial fibrillation, kidney failure, and sedatives.
Genetic influences
Genetics play a modest role in central sleep apnea overall. Most cases are linked to heart, brainstem, medications, or high-altitude exposure, not inherited variants. Rarely, genetic conditions affecting breathing control or nerve pathways increase risk in families.
Diagnosis
Diagnosis of Central sleep apnea uses an overnight sleep study (polysomnography) that tracks breathing, oxygen, and brain waves. Clinicians also review symptoms, medications, and heart or brain conditions, and exclude obstructive apnea. Home tests often miss central events.
Treatment and drugs
Central sleep apnea treatment focuses on steady breathing during sleep and easing daytime fatigue. Options may include addressing heart or nerve conditions, adjusting medicines, positive airway pressure, adaptive servo‑ventilation, oxygen, or nerve stimulation. Lifestyle steps and careful follow‑up help.
Symptoms
Feeling unrested, waking often at night, or nodding off during the day can be early symptoms of central sleep apnea. Some people wake with shortness of breath, morning headaches, or a dry mouth, while partners may notice breathing pauses. These changes can spill into the daytime, affecting memory, mood, and focus at work or while driving. Symptoms vary from person to person and can change over time.
Feeling very sleepy during the day or drifting off during quiet activities. With central sleep apnea, sleep is often too fragmented to leave you refreshed.
Waking up multiple times without a clear reason. You may feel alert or short of breath when this happens.
A bed partner may see your breathing stop briefly and then restart. In central sleep apnea, these pauses can happen with little or no snoring.
Sudden awakenings with a feeling that you can’t get enough air. Sitting up or changing position may help you catch your breath.
How people usually first notice Central sleep apnea?
Many people first notice central sleep apnea when a bed partner mentions long quiet pauses in breathing during sleep, followed by sudden gasps, or when they wake feeling unrefreshed despite a full night in bed. You might also spot unusual daytime sleepiness, morning headaches, trouble concentrating, or waking up repeatedly without a clear reason. Sometimes it’s picked up during evaluation for heart problems, stroke, or chronic opioid use, when a sleep study reveals breathing pauses without the usual snoring or blocked airway seen in obstructive sleep apnea.
Types of Central sleep apnea
Central sleep apnea has a few well-recognized types, and the differences often come down to what’s triggering the breathing pauses and when they happen during sleep. People may notice different sets of symptoms depending on their situation. Some types are tied to heart failure or high-altitude travel, while others are linked to certain medicines or brainstem conditions. Knowing the types of central sleep apnea can help you and your clinician match symptoms with the likely cause and choose the right treatment.
Primary CSA
Breathing pauses occur without an obvious external trigger. People may wake up often, feel unrefreshed, or notice daytime sleepiness. Snoring can be mild or absent compared with obstructive sleep apnea.
Cheyne–Stokes breathing
This pattern is often seen with heart failure or after a stroke. Breathing gradually waxes and wanes, with pauses in between. For many, certain types stand out more than others.
High-altitude CSA
Pauses start soon after arriving at higher elevations, typically above about 2,500 meters (8,200 feet). Symptoms often ease after acclimatization or returning to lower altitude. People may also notice periodic breathing with a cycling pattern overnight.
Medication-induced CSA
Certain drugs that slow the brain’s breathing drive, especially opioids, can cause central events. People may have frequent nighttime awakenings and daytime fatigue. Adjusting medications can reduce episodes.
Treatment-emergent CSA
Central events appear after starting CPAP or bilevel therapy for obstructive sleep apnea. This often improves over weeks as the body adapts. If it persists, clinicians may adjust settings or switch therapies.
Neurologic CSA
Breathing control problems stem from brainstem or neurologic conditions. Pauses may be more persistent and can occur across different sleep stages. Types of central sleep apnea in this group often require targeted evaluation and management.
What genetics can tell you about symptoms
Certain genetic conditions that affect the brainstem’s breathing control—like PHOX2B variants in congenital central hypoventilation—can cause pauses in breathing during sleep, shallow breaths, and daytime fatigue. Variants that alter chemoreceptor sensitivity may reduce the body’s response to carbon dioxide, triggering central sleep apnea.
Causes and risk factors
Common causes of central sleep apnea include heart failure, stroke, and problems in the brain’s breathing center.
Opioid pain medicines and staying at high altitude can trigger or worsen it.
Risk factors for central sleep apnea include older age, being male, irregular heart rhythms, and chronic kidney disease.
Rarely, an inherited condition that affects breathing control from birth is the cause.
Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Environmental and biological risk factors
Central sleep apnea happens when the brain’s breathing control briefly fails to send the signal to breathe during sleep. Risk factors for central sleep apnea include medical conditions that affect this control system and environments that destabilize breathing at night. Doctors often group risks into internal (biological) and external (environmental). Below are key environmental and biological risk factors for central sleep apnea.
As the nervous system ages, breathing control during sleep can become less steady. This can raise the chance of central sleep apnea.
Men have a higher likelihood of unstable breathing signals during sleep. Hormone and body-composition differences may contribute.
Reduced heart pumping can cause a waxing-and-waning breathing pattern known medically as Cheyne-Stokes breathing. This pattern often triggers central sleep apnea at night.
Injury to brain areas that regulate breathing can disrupt normal rhythm during sleep. Central sleep apnea may appear or worsen after a stroke or head injury.
Genetic risk factors
Some people develop central sleep apnea because of inherited conditions that affect how the brain controls breathing. These genetic causes of central sleep apnea are uncommon, but recognizing them can guide testing and care for you and your family. Carrying a genetic change doesn’t guarantee the condition will appear. Patterns vary: some start in newborns or children, while others emerge later when a genetic syndrome affects the brainstem over time.
PHOX2B variants: Changes in the PHOX2B gene cause congenital central hypoventilation syndrome, a rare condition that disrupts automatic breathing during sleep. Central sleep apnea can be a key feature, often starting in newborns or early childhood. Testing this gene is standard when doctors suspect CCHS.
CCHS-Hirschsprung link: Some people with PHOX2B changes also have Hirschsprung disease, sometimes called Haddad syndrome. This combination strongly points to a genetic driver for central sleep apnea. Family genetic counseling is often recommended.
Achondroplasia risk: Achondroplasia can narrow the opening at the base of the skull and press on the brainstem. This can trigger central sleep apnea, especially in infants and young children. Surgery to relieve pressure may be discussed.
Rett syndrome: Girls with Rett syndrome, caused by changes in MECP2, often have breathing irregularities during wake and sleep. Central apneas can occur alongside breath-holding or shallow breathing. Sleep studies help clarify the pattern.
Prader-Willi syndrome: Prader-Willi syndrome affects the brain’s regulation of breathing and arousal. People with this condition can have central sleep apnea as well as obstructive events. Regular sleep monitoring is commonly advised.
Mitochondrial disorders: Inherited mitochondrial diseases, such as Leigh syndrome, can damage brainstem areas that control breathing. Central sleep apnea may appear as the nervous system is affected. Genetic testing panels often include mitochondrial genes.
Chiari malformation: Congenital hindbrain crowding, sometimes tied to genetic conditions, can interrupt signals that drive breathing. Central sleep apnea can improve if the pressure on the brainstem is relieved. Imaging helps confirm this structural cause.
Familial dysautonomia: This inherited condition disrupts the autonomic nervous system, which includes control of breathing. Central apneas and hypoventilation can occur, especially during illness or sleep. Management focuses on monitoring and supportive care.
Lifestyle risk factors
Certain daily habits can weaken the brain’s drive to breathe or destabilize breathing control during sleep, which can worsen central sleep apnea symptoms and event frequency. The most relevant lifestyle risk factors for Central sleep apnea involve substances that depress breathing, sleep timing and quality, and choices that influence cardiovascular health. Targeted changes may reduce nighttime pauses in breathing and improve sleep continuity.
Alcohol blunts the brain’s breathing drive and can trigger or prolong central apneas during sleep. Evening drinking also fragments sleep, which makes breathing less stable overnight.
Medications like benzodiazepines or Z-drugs depress respiratory drive and arousal responses, increasing central events. Discuss safer sleep strategies with your clinician if these are used.
Opioids suppress the brainstem respiratory centers and are a well-known cause of central sleep apnea. Higher doses and bedtime dosing further increase central event frequency.
Sleep deprivation and erratic bedtimes increase ventilatory instability, making central apneas more likely. A consistent sleep-wake routine can stabilize breathing control overnight.
Risk prevention
Central sleep apnea (CSA) isn’t always preventable, because it often stems from heart, brain, or medication effects. Knowing your risks can guide which preventive steps matter most. You can lower risk by protecting heart health, reviewing medicines that slow breathing, and planning for high altitude. Spotting early symptoms of central sleep apnea and getting timely care can also prevent complications.
Keeping heart failure and atrial fibrillation well managed can lower the chance of CSA. Regular follow-ups, taking medicines as prescribed, and staying active within your limits help stabilize nighttime breathing.
Opioids and certain sleep medicines can reduce the brain’s drive to breathe during sleep, increasing CSA risk. Work with your doctor to lower doses, switch to safer options, or taper when appropriate—never stop suddenly.
Limiting alcohol, especially within a few hours of bedtime, helps protect natural breathing rhythms. Avoid combining alcohol with sedatives, which can further suppress breathing during sleep.
Rapid ascent to high altitude can trigger central sleep apnea in some people. Ascend gradually, build in acclimatization days, and ask your doctor if a preventive medicine for altitude-related breathing would be right for you.
Transmission
People often ask whether central sleep apnea is contagious—it isn’t. You can’t catch it or pass it on through coughing, kissing, sharing a bed or room, or everyday contact.
Most central sleep apnea develops because of other health conditions, certain medicines such as opioids, or sleeping at high altitude, not from exposure to someone else. A rare form present from birth can run in families, but that is a distinct diagnosis; typical central sleep apnea is not inherited.
When to test your genes
Central sleep apnea is usually evaluated with a sleep study first; consider genetic testing only if there’s a strong family history of central apnea or related congenital breathing or brainstem disorders. Test sooner if symptoms start in childhood or alongside unexplained neurologic features. Otherwise, tailor care based on sleep study findings and underlying causes.
Diagnosis
Central sleep apnea is usually picked up when breathing pauses or restless nights start affecting daily life—often noticed by a bed partner before you do. You might wake up repeatedly, feel very sleepy during the day, or notice sudden shortness of breath at night. Often, it’s a family member who first points out changes that lead to testing. The diagnosis of central sleep apnea looks at your symptoms, sleep patterns, and any medical conditions or medicines that can disrupt your brain’s control of breathing.
Doctors usually begin by asking about nighttime breathing pauses, gasping, fragmented sleep, and daytime sleepiness. They’ll also ask about heart or brain conditions, altitude exposure, opioid or sedative use, and alcohol.
Reports of quiet pauses in breathing without obvious snoring can be a helpful clue. Loved ones may notice a pattern of stop–start breathing or periodic breathing through the night.
Your provider checks for signs of heart failure, irregular heartbeat, or neurological changes. They also look for breathing patterns that suggest unstable control of breathing, such as periodic, waxing-and-waning breaths.
A lab-based sleep study measures brain waves, airflow, oxygen, and chest and belly effort to confirm central events, which show reduced or absent breathing effort. This test distinguishes central sleep apnea from obstructive sleep apnea and quantifies how severe it is; it’s central to the diagnosis of central sleep apnea.
Stages of Central sleep apnea
Central sleep apnea does not have defined progression stages. It can fluctuate over time and is usually identified by sleep study findings rather than a steady, step-by-step worsening, and symptoms may ebb and flow with factors like sleep position, altitude, medicines, or an underlying heart or neurological condition. Different tests may be suggested to help confirm what’s going on—typically an overnight sleep study (polysomnography) that measures breathing patterns, oxygen levels, and the number of central apneas, sometimes alongside heart and lung checks. If you notice early symptoms of central sleep apnea like witnessed pauses in breathing, frequent awakenings, or daytime sleepiness, a sleep specialist may monitor changes over time and adjust treatment based on repeat studies and your overall health.
Outlook and prognosis
Sleeping can feel unpredictable with central sleep apnea, especially when nights of fragmented rest spill into daytime fatigue or trouble concentrating. Many people ask, “What does this mean for my future?”, and the answer depends on what’s driving the breathing pauses—heart disease, stroke, certain medicines, high altitude exposure, or an idiopathic form with no clear cause. Prognosis refers to how a condition tends to change or stabilize over time. When central sleep apnea is tied to a treatable trigger, addressing that root cause often improves sleep quality and cuts down on pauses. For others, symptoms may ebb and flow, and early symptoms of central sleep apnea—like waking gasping, morning headaches, or feeling unrefreshed—can improve with consistent treatment.
The outlook is not the same for everyone, but people with central sleep apnea linked to heart failure or prior stroke tend to have a higher risk of complications if the condition goes untreated. In these groups, central sleep apnea can be a marker of more severe heart or brain disease, and untreated cases are associated with worse quality of life and, in some studies, higher mortality. The good news is that targeted care—optimizing heart failure therapy, adjusting medications like opioids when possible, using appropriate breathing support at night, or addressing altitude—can reduce breathing pauses and may improve daytime alertness and cardiovascular strain. Some people experience long stretches of stable sleep with therapy, while others notice periodic returns of symptoms that call for fine-tuning the plan.
Looking at the long-term picture can be helpful. With ongoing care, many people maintain good daily functioning and safer sleep, though regular follow-up is important because needs can change over time. If central sleep apnea develops during high-altitude stays, it often resolves after descent; if it begins after a stroke, it may lessen as the brain recovers, though some residual symptoms can persist. When central sleep apnea is idiopathic, outcomes vary, but many living with central sleep apnea find that consistent use of prescribed therapies and management of other health conditions keeps symptoms manageable. Talk with your doctor about what your personal outlook might look like, especially if you have heart or neurologic conditions, so you can match the treatment plan to your goals and risks.
Long-term effects
Central sleep apnea can affect how rested and clear-headed you feel during the day, and over time it may influence heart and brain health. The outlook depends a lot on the underlying cause—such as heart failure, opioid use, or a past stroke—and how those issues change over time. Long-term effects vary widely, but commonly include persistent tiredness, problems with attention or mood, and cardiovascular strain. Doctors often follow people over years to see how sleep quality and related health conditions evolve.
Ongoing broken sleep can leave you tired, sluggish, or nodding off during the day. This can make work, school, or driving feel harder and less safe.
Trouble focusing, remembering details, or thinking quickly can build over time. Many notice tasks that once felt easy now take more effort.
Irritability, low mood, or anxiety may become more common with poor-quality sleep. These changes can strain relationships and lower motivation.
Repeated nighttime breathing pauses can trigger waking with head pain. Headaches often ease later in the day but may recur.
How is it to live with Central sleep apnea?
Living with central sleep apnea can feel puzzling because the body “forgets” to breathe during sleep, leaving many people waking unrefreshed, foggy, or with morning headaches despite spending a full night in bed. Daytime sleepiness, trouble concentrating, and mood changes can ripple into work, driving, and relationships, while bed partners may notice pauses in breathing or restless nights and feel worried or sleep-deprived themselves. For many, consistent treatment—such as optimized medical care for underlying conditions, specialized breathing support at night, and steady sleep routines—brings clearer days and calmer nights. Reassurance matters: with the right plan and follow‑through, most people regain energy, safer sleep, and confidence in daily life.
Treatment and drugs
Central sleep apnea treatment focuses on improving breathing during sleep, easing daytime fatigue, and addressing the underlying cause. Doctors first look for triggers such as heart failure, stroke, certain medicines (especially opioids), high altitude exposure, or other medical conditions, and treat those directly when possible. Positive airway pressure at night is common; options include CPAP, bilevel PAP, or adaptive servo-ventilation, which adjusts support breath by breath to stabilize your breathing. If needed, medicines like acetazolamide, reducing or changing sedating medications, supplemental oxygen, or a pacemaker-like device that stimulates the phrenic nerve may be considered, especially when central sleep apnea persists despite first steps. Not every treatment works the same way for every person, so your doctor may fine-tune therapy over time and track sleep studies to see what helps most.
Non-drug treatment
Central sleep apnea can leave people waking unrefreshed, foggy, and struggling with daytime energy. Alongside medicines, non-drug therapies can steady nighttime breathing and improve sleep quality. People sometimes miss early symptoms of central sleep apnea, such as frequent awakenings or morning headaches, until a partner notices pauses in breathing. Your team will tailor options based on the cause, your heart–lung health, and sleep study results.
A bedside device delivers gentle air through a mask to stabilize breathing and prevent pauses. Settings are adjusted during a sleep study to match your needs.
This advanced device gives breath-by-breath support to smooth out irregular breathing in central sleep apnea. It is not suitable for some people with certain types of heart failure, so safety is checked first.
Low-flow oxygen at night can reduce the number of central events and improve blood oxygen levels. Your care team sets the flow and monitors you to keep levels safe.
An implanted system gently stimulates the nerve that drives the diaphragm to prompt consistent breaths during sleep. It is considered when other options like PAP are not enough and requires ongoing follow-up.
Your genes may have an impact on how drugs work for you
Some central sleep apnea medicines work differently depending on genetic differences in drug‑processing enzymes, which can change how quickly a dose is cleared or how strong it feels. Genes can also affect opioid sensitivity, raising CSA risk and guiding safer, lower‑dose choices.
Pharmacological treatments
Medicines can help some people with central sleep apnea (CSA), especially when devices like PAP are not enough or aren’t tolerated. Not everyone responds to the same medication in the same way. These options aim to steady breathing during sleep, reduce pauses, and improve daytime alertness. They are not a first choice for early symptoms of central sleep apnea, which are usually checked with a sleep study.
This medicine nudges your body to breathe a bit deeper and more regularly overnight. Dosing may be increased or lowered gradually to balance benefits and side effects.
This mild stimulant can boost the drive to breathe and may reduce central apneas. It needs careful monitoring because side effects like jitteriness, heart rhythm changes, and stomach upset can occur.
These sleep aids may help stabilize breathing in select cases of CSA by reducing frequent awakenings. They can worsen obstructive apnea or cause next-day drowsiness, so specialists use them cautiously.
This anti-anxiety medicine may gently increase breathing drive and has been explored for CSA in small studies. Benefits are modest and evidence is limited, so it’s usually considered only when other options fall short.
Genetic influences
For most people living with central sleep apnea, genes seem to play a smaller role than other factors like heart or neurologic conditions, certain medicines (such as opioids), or staying at high altitude. It’s natural to ask whether family history plays a role. Research suggests there may be subtle inherited differences in how the brain senses carbon dioxide and regulates breathing during sleep, which could raise susceptibility, but clear-cut, strongly inherited forms of central sleep apnea are uncommon. Rare genetic syndromes that affect the body’s automatic control of breathing can include central apneas, usually beginning in infancy or childhood, but these are not the typical pattern seen in adults. Because many cases of central sleep apnea are secondary to other health issues, a family history of heart failure, stroke, or neurologic disease may matter more than a family history of central sleep apnea itself. If early symptoms of central sleep apnea show up in several relatives—like pauses in breathing during sleep without much snoring—talking with your clinician about your family history can help decide whether genetic counseling or other testing might be useful.
Is Central sleep apnea genetic?
Genetics play a modest role in central sleep apnea overall. Most cases are linked to heart, brainstem, medications, or high-altitude exposure, not inherited variants. Rarely, genetic conditions affecting breathing control or nerve pathways increase risk in families.
Pharmacogenetics—how genetics influence drug effects
Genetics can shape how certain medicines used in the care of central sleep apnea affect you, especially drugs that influence breathing. Differences in how your liver enzymes work can change your response to codeine or tramadol; some people break them down quickly and feel stronger effects on breathing, while others process them slowly and get little pain relief. Genetic testing can sometimes identify how your body handles these medicines, and pharmacogenetic testing for central sleep apnea care may help your doctor choose safer options or adjust doses. Genes that affect liver enzymes also matter for theophylline, a rarely used stimulant medicine, because small changes in blood levels can tip it from helpful to causing side effects, including palpitations or trouble sleeping. Device-based treatments for central sleep apnea, like positive airway pressure or phrenic nerve stimulation, aren’t guided by pharmacogenetics, but your genetic profile may still guide which sedatives, pain medicines, or other drugs to avoid or use carefully. Genetics doesn’t replace a full review of your sleep study, medical history, and other factors, yet it can reduce trial and error when medicines are part of your treatment plan.
Interactions with other conditions
Central sleep apnea often occurs alongside heart conditions like heart failure and atrial fibrillation, and each can influence the other. Doctors call it a “comorbidity” when two conditions occur together. In people with heart failure, central sleep apnea can trigger a Cheyne–Stokes breathing pattern and may worsen daytime fatigue and heart rhythm problems; treating the heart failure well can sometimes ease the breathing pauses. Stroke, brainstem injury, and some neurological diseases can disrupt the brain’s breathing control and lead to central sleep apnea, while opioid pain medicines can suppress breathing drive and make central events more frequent. Central sleep apnea can also overlap with obstructive sleep apnea, so a sleep study helps sort out which type is present because treatments differ. Because early symptoms of central sleep apnea can be subtle, issues like new or worsening irregular heartbeat, morning headaches, or poor concentration may be the first clues. If heart failure with a reduced ejection fraction is present, certain advanced breathing devices (adaptive servo-ventilation) are not advised, so care teams tailor therapy to the combination of conditions and medications.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described restless nights where breathing seemed to “pause” in sleep, with bed partners noticing long, silent gaps followed by a gasp. Community stories often described the condition as haunting nighttime stillness, then sudden snorts that startled everyone awake. These lived observations came long before doctors understood that, in central sleep apnea, the brain’s signal to breathe fades in and out during sleep.
From early case notes in the 19th and early 20th centuries, physicians recorded puzzling nighttime breathing patterns without a clear cause in the lungs or airways. Initially understood only through symptoms, later sleep laboratories allowed continuous tracking of airflow, chest movement, oxygen levels, and brain waves. That shift made it possible to separate central sleep apnea from obstructive sleep apnea, where the airway physically collapses. As overnight testing spread in the late 20th century, researchers also recognized special patterns such as Cheyne–Stokes breathing in heart failure, where breathing waxes and wanes in a repeating cycle.
Advances in heart and brain care changed the story further. As cardiology improved and more people lived with chronic heart failure or after strokes, clinicians saw central sleep apnea more often in these groups. In recent decades, knowledge has built on a long tradition of observation. Large studies linked central sleep apnea with conditions that alter the brain’s breathing control, the heart’s pumping, and blood carbon dioxide levels. At high altitude, for example, some otherwise healthy travelers developed temporary central apneas until their bodies adjusted.
Therapies evolved alongside understanding. Early approaches focused on oxygen and breathing support at night. Later came positive airway pressure devices tuned for central patterns, followed by options like adaptive servo-ventilation and, more recently, implantable nerve stimulators that help steady the breathing rhythm in selected people. At the same time, researchers learned that treating the underlying condition—such as optimizing heart failure therapy or reducing certain medications like opioids—could reduce central events.
The language around central sleep apnea has also grown more precise. Over time, descriptions became standardized into subtypes based on cause and breathing pattern, helping clinicians choose tests and treatments. Despite evolving definitions, the core experience for people living with central sleep apnea has remained recognizable: disrupted, unrefreshing sleep and daytime fatigue, often noticed first by a partner who hears the quiet pauses. Knowing the condition’s history highlights why careful sleep testing and a tailored plan matter today.